By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Cytos Biotechnology AG 

Wagistrasse 25

Postfach  Zurich-Schlieren  8952  Switzerland
Phone: 41-1-733-47-47 Fax: 41-1-733-47-40


SEARCH JOBS


Industry
Biotechnology






Company News
Cytos Biotechnology AG's Asthma Drug CYT003 Flunks Pivotal Phase 2b Study 4/14/2014 7:19:17 AM
Cytos Biotechnology AG Rights Offering Oversubscribed - CHF 24.3 Million Raised 11/18/2013 6:58:30 AM
Cytos Biotechnology AG to Host Investor and Analyst R&D Day in New York City 10/17/2013 11:53:03 AM
Cytos Biotechnology AG Presents Additional Results From Phase 2a Study of CYT003 for the Treatment of Allergic Asthma 9/9/2013 8:42:02 AM
Cytos Biotechnology AG Reports Second Quarter 2013 Financial Results and Recent Developments 8/6/2013 6:47:16 AM
A*STAR and Cytos Biotechnology AG Bring Singapore's First Influenza Vaccine to Clinical Testing 5/17/2013 9:07:43 AM
Cytos Biotechnology AG Reports First Quarter 2013 Financial Results and Recent Development 4/25/2013 6:53:41 AM
The Journal of Allergy and Clinical Immunology Publishes Phase 2a Study Results With Cytos Biotechnology AG’s CYT003 for the Treatment of Allergic Asthma 3/13/2013 9:34:58 AM
Cytos Biotechnology AG VLP Platform is Basis for Phase 1 Clinical Trial with Anti-IgE Vaccine 2/4/2013 9:44:06 AM
Cytos Biotechnology AG Reports Third Quarter 2012 Financial Results, Recent Development and Outlook 11/6/2012 10:20:06 AM
1234
//-->